Delivery of small molecules for bone regenerative engineering: Preclinical studies and potential clinical applications

Drug Discovery Today

Volumn 19, Issue 6, 2014, Pages 794-800

  Laurencin, Cato T ^a,b   Ashe, Keshia M ^a,b   Henry, Nicole ^b   Kan, Ho Man ^a   Lo, Kevin W H ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CERAMIC; CHITOSAN; FINGOLIMOD; HELIOXANTHIN DERIVATIVE; HYDROXYAPATITE; MEVINOLIN; NANOPARTICLE; OXYSTEROL; POLYGLACTIN; PURMORPHAMINE; ROLIPRAM; ROSUVASTATIN; SIMVASTATIN; SVAK 12; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; SIGNAL PEPTIDE;

BONE DISEASE; BONE INJURY; BONE REGENERATION; BONE REMODELING; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; FRACTURE; MOLECULAR MEDICINE; MOLECULAR SIZE; NONHUMAN; OSTEOPOROSIS; REVIEW; SPINE FUSION; SUSTAINED DRUG RELEASE; TISSUE ENGINEERING; ANIMAL; BONE DISEASES; DRUG EFFECTS; DRUG SCREENING; FRACTURES, BONE; HUMAN; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATIVE MEDICINE;

ANIMALS; BONE DISEASES; BONE REGENERATION; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; FRACTURES, BONE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 84902082590     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.01.012     Document Type: Review

References (99)

1. C.T. Laurencin, and Y. Khan Regenerative engineering Sci. Transl. Med. 4 2012 160 169
2. C.H. Evans Advances in regenerative orthopedics Mayo Clin. Proc. 88 2013 1323 1339
3. M.R. Urist Bone: formation by autoinduction Science 150 1965 893 899
4. J.R. Lieberman et al. The role of growth factors in the repair of bone. Biology and clinical applications J. Bone Joint Surg. Am. 84 2002 1032 1044
5. P.C. Bessa et al. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery) J. Tissue Eng. Regen. Med. 2 2008 81 96
6. K.W-H. Lo et al. Studies of bone morphogenetic protein based surgical repair Adv. Drug Deliv. Rev. 64 2012 1277 1291
7. Q. Cui et al. Combined angiogenic and osteogenic factor delivery for bone regenerative engineering Curr. Pharm. Des. 19 2013 3374 3383
8. M.J. Cho, and R. Juliano Macromolecular versus small-molecule therapeutics: drug discovery, development and clinical considerations Trends Biotechnol. 14 1996 153 158 (Pubitemid 26163446)
9. M. Baker, and F. Carr Pre-clinical considerations in the assessment of immunogenicity for protein therapeutics Curr. Drug Saf. 5 2010 308 313
10. K.W. Lo et al. Current patents on osteoinductive molecules for bone tissue engineering Recent Pat. Biomed. Eng. 4 2011 153 167
11. K.W-H. Lo et al. The role of small molecules in the musculoskeletal regeneration Regen. Med. 7 2012 535 549
12. Q.Q. Han et al. The role of small molecules in bone regeneration Future Med. Chem. 5 2013 1671 1684
13. K. Fu et al. Protein stability in controlled-release systems Nat. Biotechnol. 18 2000 24 25 (Pubitemid 30041164)
14. M. Kessler et al. Immunogenicity of biopharmaceuticals Nephrol. Dial. Transplant. 21 Suppl. 5 2006 v9 v12
15. C.J. Hwang et al. Immunogenicity of bone morphogenetic proteins J. Neurosurg. Spine 10 2009 443 451
16. H. Egusa et al. A small-molecule approach to bone regenerative medicine in dentistry J. Oral Biosci. 52 2010 107 118
17. C.E. Segar et al. Regulation of angiogenesis and bone regeneration with natural and synthetic small molecules Curr. Pharm. Des. 19 2013 3403 3419
18. K.W-H. Lo et al. Small molecule based musculoskeletal regenerative engineering Trends Biotechnol. 32 2014 74 81
19. G. Blaich et al. Overview: differentiating issues in the development of macromolecules compared with small molecules S.C. Gad, Handbook of Pharmaceutical Biotechnology 2006 John Wiley & Sons 10.1002/9780470117118. ch1c
20. K.A. Wieghaus et al. Small molecule inducers of angiogenesis for tissue engineering Tissue Eng. 12 2006 1903 1913 (Pubitemid 44162849)
21. H. Hojo et al. Development of high-throughput screening system for osteogenic drugs using a cell-based sensor Biochem. Biophys. Res. Commun. 376 2008 375 379
22. C.Y. Han et al. Small molecules with potent osteogenic-inducing activity in osteoblast cells Bioorg. Med. Chem. Lett. 19 2009 1442 1445
23. D.M. Brey et al. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation Biotechnol. Bioeng. 108 2011 163 174
24. H. Alves et al. High-throughput assay for the identification of compounds regulating osteogenic differentiation of human mesenchymal stromal cells PLoS ONE 6 2011 e26678
25. A. Darcy et al. A novel library screen identifies immunosuppressors that promote osteoblast differentiation Bone 50 2012 1294 1303
26. K. Vrijens et al. Identification of small molecule activators of BMP signaling PLoS ONE 8 2013 e59045
27. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S81 S91
28. S.Y. Lin et al. Microencapsulation and controlled release of insulin from polylactic acid microcapsules Biomater. Med. Devices Artif. Organs 13 1985 187 201
29. C. Ustariz-Peyret et al. Cephradin-plaga microspheres for sustained delivery to cattle J. Microencapsul. 16 1999 181 194 (Pubitemid 29099600)
30. M.J. Alonso et al. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems Vaccine 12 1994 299 306 (Pubitemid 24071950)
31. D.T. Birnbaum et al. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release J. Control. Release 65 2000 375 387 (Pubitemid 30122940)
32. M. Boisdron-Celle et al. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers J. Pharm. Pharmacol. 47 1995 108 114
33. Z.G. Chen Small-molecule delivery by nanoparticles for anticancer therapy Trends Mol. Med. 16 2010 594 602
34. B. Dhandayuthapani et al. Polymeric scaffolds in tissue engineering application: a review Int. J. Polym. Sci. 2011 10.1155/2011/290602
35. A.J. Salgado et al. Bone tissue engineering: state of the art and future trends Macromol. Biosci. 4 2004 743 765 (Pubitemid 39257140)
36. Y. Khan et al. Tissue engineering of bone: material and matrix considerations J. Bone Joint Surg. Am. 90 Suppl. 1 2008 36 42 (Pubitemid 351329119)
37. S. Samavedi et al. Calcium phosphate ceramics in bone tissue engineering: a review of properties and their influence on cell behavior Acta Biomater. 9 2013 8037 8045
38. S.H. Lee, and H. Shin Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering Adv. Drug Deliv. Rev. 59 2007 339 359 (Pubitemid 46879973)
39. H.K. Makadia, and S.J. Siege Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier Polymers 3 2011 1377 1397
40. L. Hu et al. Advances in chitosan-based drug delivery vehicles Nanoscale 5 2013 3103 3111
41. Y.I. Chung et al. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex J. Control. Release 121 2007 91 99
42. F.R. Maia et al. Functionalization of biomaterials with small osteoinductive moieties Acta Biomater. 9 2013 8773 8789
43. C.R. Nuttelman et al. Dexamethasone-functionalized gels induce osteogenic differentiation of encapsulated hMSCs J. Biomed. Mater. Res. A 76 2006 183 195 (Pubitemid 43075696)
44. K.L. Steinmetz, and E.G. Spack The basics of preclinical drug development for neurodegenerative disease indications BMC Neurol. 9 Suppl. 1 2009 S2
45. S. Honig Osteoporosis: new treatments and updates Bull. NYU Hosp. Jt. Dis. 69 2010 253 256
46. L. Mosekilde et al. The pathogenesis, treatment and prevention of osteoporosis in men Drugs 73 2013 15 29
47. C. Deal, and J. Gideon Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis Cleve. Clin. J. Med. 70 2003 585 601 (Pubitemid 36939959)
48. R. Kothari et al. Modes of degradation and impurity characterization in rhPTH (1-34) during stability studies PDA J. Pharm. Sci. Technol. 65 2011 348 362
49. G. Mundy et al. Stimulation of bone formation in vitro and in rodents by statins Science 286 1999 1946 1949 (Pubitemid 129515901)
50. A. Helin-Salmivaara et al. Statins and hip fracture prevention: a population based cohort study in women PLoS ONE 7 2012 e48095
51. T. Ito et al. Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat J. Mater. Sci. Mater. Med. 23 2012 1291 1297
52. T. Ito et al. Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice J. Pharm. Pharmacol. 65 2013 494 502
53. Z. Du et al. Effects of simvastatin on bone healing around titanium implants in osteoporotic rats Clin. Oral Implants Res. 20 2009 145 150
54. G. Yang et al. Bone responses to simvastatin-loaded porous implant surfaces in an ovariectomized model Int. J. Oral Maxillofac. Implants 27 2012 369 374
55. V.A. Stadelmann et al. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporotic sheep model. A pilot study Eur. Cell Mater. 16 2008 10 16
56. J.A. Buckwalter et al. Bone biology. I: structure, blood supply, cells, matrix, and mineralization Instr. Course Lect. 45 1996 371 386
57. S.N. Khan et al. The biology of bone grafting J. Am. Acad. Orthop. Surg. 13 2005 77 86
58. C.T. Laurencin et al. Bone graft substitutes Expert Rev. Med. Devices 3 2006 49 57
59. C.T. Laurencin et al. Tissue engineering: orthopedic applications Annu. Rev. Biomed. Eng. 1 1999 19 46 (Pubitemid 129740004)
60. C.E. Petrie Aronin et al. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720 Biomaterials 31 2010 6417 6424
61. L.S. Sefcik et al. Selective activation of sphingosine 1-phosphate receptors 1 and 3 promotes local microvascular network growth Tissue Eng. A 17 2011 617 629
62. C. Huang et al. Local delivery of FTY720 accelerates cranial allograft incorporation and bone formation Cell Tissue Res. 347 2012 553 566
63. X. Wu et al. Purmorphamine induces osteogenesis by activation of the Hedgehog signaling pathway Chem. Biol. 11 2004 1229 1238 (Pubitemid 39282798)
64. K. Gellynck et al. Small molecule stimulation enhances bone regeneration but not titanium implant osseointegration Bone 57 2013 405 412
65. K.W. Park et al. The small molecule phenamil induces osteoblast differentiation and mineralization Mol. Cell. Biol. 29 2009 3905 3914
66. S. Kato et al. A synthetic compound that potentiates bone morphogenetic protein-2-induced transdifferentiation of myoblasts into the osteoblastic phenotype Mol. Cell. Biochem. 349 2011 97 106
67. E. Wong et al. A novel low-molecular-weight compound enhances ectopic bone formation and fracture repair J. Bone Joint Surg. Am. 95 2013 454 461
68. R.W. Wong, and A.B. Rabie Effect of Buguzhi (Psoralea corylifolia fruit) extract on bone formation Phytother. Res. 24 Suppl. 2 2010 S155 S160
69. R.W. Wong, and A.B. Rabie Effect of psoralen on bone formation J. Orthop. Res. 29 2011 158 164
70. R.W. Wong, and A.B. Rabie Effect of daidzein on bone formation Front. Biosci. 14 2009 3673 3679
71. R.W. Wong, and A.B. Rabie Effect of genistin on bone formation Front. Biosci. 2 2010 764 770
72. R.W. Wong, and A.B. Rabie Effect of quercetin on preosteoblasts and bone defects Open Orthop. J. 2 2008 27 32
73. I.C. Tai et al. Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair Int. J. Nanomed. 8 2013 3895 3905
74. S. Kumar, and S. Ponnazhagan Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect Bone 50 2012 1012 1018
75. H. Shao et al. OIC-A006-loaded true bone ceramic heals rabbit critical-sized segmental radial defect Pharmazie 67 2012 247 252
76. M. Yamada et al. N-acetyl cysteine as an osteogenesis-enhancing molecule for bone regeneration Biomaterials 34 2013 6147 6156
77. B. Peng et al. Diagnosis and surgical treatment of back pain originating from endplate Eur. Spine J. 18 2009 1035 1040
78. A.J. Freemont The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain Rheumatology 48 2009 5 10
79. C. Becker Spine-tingling prospects: artificial disc implants are among the new technologies expected to revolutionize the outcomes of back surgery Mod. Healthc. 33 2003 30 32
80. B. Bostan et al. Simvastatin improves spinal fusion in rats Acta Orthop. Traumatol. Turc. 45 2011 270 275
81. A.J. Yee et al. The use of simvastatin in rabbit posterolateral lumbar intertransverse process spine fusion Spine J. 6 2006 391 396 (Pubitemid 43977196)
82. J.S. Johnson et al. Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo J. Cell. Biochem. 112 2011 1673 1684
83. F. Stappenbeck et al. Novel oxysterols activate the Hedgehog pathway and induce osteogenesis Bioorg. Med. Chem. Lett. 22 2012 5893 5897
84. L. Brouwers et al. Network neighbors of drug targets contribute to drug side-effect similarity PLoS ONE 6 2011 e22187
85. W.A. Weiss et al. Recognizing and exploiting differences between RNAi and small-molecule inhibitors Nat. Chem. Biol. 3 2007 739 744 (Pubitemid 350126879)
86. K-W.H. Lo et al. One-day treatment of small molecule 8-bromo-cyclic amp analogue induces cell-based VEGF production for in vitro angiogenesis and osteoblastic differentiation J. Tissue Eng. Regen. Med. 2013 10.1002/term.1839
87. K-W.H. Lo et al. Short-term treatment of small molecule phenamil induced a protracted osteogenic effect on osteoblast-like MC3T3-E1 cells J. Tissue Eng. Regen. Med. 2013 10.1002/term.1786
88. H.B. Ravivarapu et al. Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant AAPS PharmSciTech 1 2000 E1
89. P.Q. Ruhe et al. Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo J. Control. Release 106 2005 162 171 (Pubitemid 41140091)
90. P. Agarwal, and I.D. Rupenthal Injectable implants for the sustained release of protein and peptide drugs Drug Discov. Today 18 2013 337 349
91. B.D. Ulery et al. Facile fabrication of polyanhydride/anesthetic nanoparticles with tunable release kinetics Adv. Healthc. Mater. 2013 10.1002/adhm.201300521
92. W.B. Liechty et al. Polymers for drug delivery systems Annu. Rev. Chem. Biomol. Eng. 1 2010 149 173
93. D.C. Bibby et al. Poly(acrylic acid) microspheres containing beta-cyclodextrin: loading and in vitro release of two dyes Int. J. Pharm. 187 1999 243 250 (Pubitemid 29443904)
94. M. Deng et al. Nanostructured polymeric scaffolds for orthopaedic regenerative engineering IEEE Trans. Nanobiosci. 11 2012 3 14
95. Y. Qi et al. Mesenchymal stem cell sheet transplantation combined with locally released simvastatin enhances bone formation in a rat tibia osteotomy model Cytotherapy 15 2013 44 56
96. T. Yoshii et al. Local injection of lovastatin in biodegradable polyurethane scaffolds enhances bone regeneration in a critical-sized segmental defect in rat femora J. Tissue Eng. Regen. Med. 2012 10.1002/term.1547
97. M. Monjo et al. In vivo performance of absorbable collagen sponges with rosuvastatin in critical-size cortical bone defects Acta Biomater. 6 2010 1405 1412
98. Y. Maeda et al. Bone healing by sterilizable calcium phosphate tetrapods eluting osteogenic molecules Biomaterials 34 2013 5530 5537
99. T.L. Downing et al. Drug-eluting microfibrous patches for the local delivery of rolipram in spinal cord repair J. Control. Release 161 2012 910 917